Micro-invasive pancreaticoduodenectomy will be a promising treatment option for distal cholangiocarcinoma
- PMID: 39507723
- PMCID: PMC11534782
- DOI: 10.21037/hbsn-24-331
Micro-invasive pancreaticoduodenectomy will be a promising treatment option for distal cholangiocarcinoma
Keywords: Distal cholangiocarcinoma (dCCA); minimally invasive pancreaticoduodenectomy (MIPD); prognosis.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-24-331/coif). The authors have no conflicts of interest to declare.
Comment on
-
Long-term Outcomes After Laparoscopic, Robotic, and Open Pancreatoduodenectomy for Distal Cholangiocarcinoma: An International Propensity Score-matched Cohort Study.Ann Surg. 2023 Sep 1;278(3):e570-e579. doi: 10.1097/SLA.0000000000005743. Epub 2022 Nov 1. Ann Surg. 2023. PMID: 36730852
References
-
- Kim SH, Lee B, Hwang HK, et al. Comparison of postoperative complications and long-term oncological outcomes in minimally invasive versus open pancreatoduodenectomy for distal cholangiocarcinoma: A propensity score-matched analysis. J Hepatobiliary Pancreat Sci 2022;29:329-37. 10.1002/jhbp.1067 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources